AACR Past-president Carlos Arteaga to Receive Prestigious Medical Award
Carlos L. Arteaga, MD, past-president of the AACR, has been selected to receive the 2015 Prize for Scientific Excellence...
Carlos L. Arteaga, MD, past-president of the AACR, has been selected to receive the 2015 Prize for Scientific Excellence...
Eddy Shih-Hsin Yang, MD, PhD, associate professor and Regional Oncology Active Research (ROAR) Southeast Cancer Foundation Endowed Chair at...
Jamie Holloway, a breast cancer researcher turned breast cancer patient and AACR Scientist↔Survivor Program advocate, started a blog to...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...
Ductal carcinoma in situ (DCIS)—stage 0 breast cancer that starts in a duct and has not spread into surrounding...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...